Family-based associations in measures of psychological distress and quality of life in a cardiac screening clinic for inheritable cardiac diseases: a cross-sectional study

BMC Medical Genetics

Mary Codd¹  Niall G Mahon⁴  Kevin Malone²  Joseph Galvin³  Jim O Neill³  Ted Keelan³  Colin McQuade⁴  Charlene McShane¹  Catherine McGorrian¹ 

[1] UCD School of Public Health, Physiotherapy and Population Science, University College Dublin, Dublin, Ireland;Department of Psychiatry and Mental Health Research, St Vincent’s University Hospital, Dublin, 4, Ireland;Department of Cardiology, Connolly Hospital, Blanchardstown, Dublin, 15, Ireland;The Heart House, Mater Misericordiae University Hospital, Dublin, 7, Ireland

关键词: Family-based evaluation;    Depression;    Anxiety;    Sudden arrhythmic death syndrome;    Sudden cardiac death;    Channelopathy;    Inherited cardiac diseases;    Screening;   

Others  :  1177754
DOI  :  10.1186/1471-2350-14-1

 received in 2012-05-17, accepted in 2012-12-17,  发布年份 2013

【 摘 要 】

Background

Family-based cardiac screening programmes for persons at risk for genetic cardiac diseases are now recommended. However, the psychological wellbeing and health related quality of life (QoL) of such screened patients is poorly understood, especially in younger patients. We sought to examine wellbeing and QoL in a representative group of adults aged 16 and over in a dedicated family cardiac screening clinic.

Methods

Prospective survey of consecutive consenting patients attending a cardiac screening clinic, over a 12 month period. Data were collected using two health measurement tools: the Short Form 12 (version 2) and the Hospital Anxiety and Depression Scale (HADS), along with baseline demographic and screening visit-related data. The HADS and SF-12v.2 outcomes were compared by age group. Associations with a higher HADS score were examined using logistic regression, with multi-level modelling used to account for the family-based structure of the data.

Results

There was a study response rate of 86.6%, with n=334 patients providing valid HADS data (valid response rate 79.5%), and data on n=316 retained for analysis. One-fifth of patients were aged under 25 (n=61). Younger patients were less likely than older to describe significant depression on their HADS scale (p<0.0001), although there were overall no difference between the prevalence of a significant HADS score between the younger and older age groups (18.0% vs 20.0%, p=0.73). Significant positive associates of a higher HADS score were having lower educational attainment, being single or separated, and being closely related to the family proband. Between-family variance in anxiety and depression scores was greater than within-family variance.

Conclusions

High levels of anxiety were seen amongst patients attending a family-based cardiac screening clinic.Younger patients also had high rates of clinically significant anxiety. Higher levels of anxiety and depression tends to run in families, and this has implications for family screening and intervention programmes.

【 授权许可】

   
2013 McGorrian et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Nunn L, Lambiase P: Genetics and cardiovascular disease – cause and prevention of unexpected sudden adult death: the role of the SADS clinic. Heart 2011, 97:1122-1127.
• [2]Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, et al.: HRS/EHRA Expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Hear Rhythm 2011, 8:1308-1339.
• [3]Ackerman MJ, Tester DJ, Driscoll DJ: Molecular autopsy of sudden unexplained death in the young. Am J Forensic Med Pathol 2001, 22:105-111.
• [4]Behr ER, Dalageorgou C, Christiansen M, Syris P, Hughes S, Tome Esteban MT, Rowland E, Jeffery S, McKenna WJ: Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in majority of families. Eur Heart J 2008, 29:1670-1680.
• [5]Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA: Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005, 112:207-203.
• [6]van der Werf C, Hofman N, Tan HL, van Dessel PF, Alders M, van der Wal AC, van Langen IM, Wilde AA: Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Hear Rhythm 2010, 7:1383-1389.
• [7]Caldwell J, Moreton N, Khan N, Metcalfe K, Newman W, Garratt CJ, Kerzin-Storrar: The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated. Heart 2012, 98:631-636.
• [8]McGorrian C, Constant O, Harper N, O’Donnell C, Codd M, Keelan S, Green A, O’Neill J, Galvin J, Mahon N: Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome. 2012. [EP-Europace] in press
• [9]Maron BJ: Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2010, 121:445-456.
• [10]Goldenberg I, Zareba W, Moss AJ: Long QT Syndrome. Curr Probl Cardiol 2008, 33:629-694.
• [11]Sen-Chowdhry S, McKenna W: Sudden cardiac death in the young: a strategy for prevention by targeted evaluation. Cardiology 2006, 105(4):196-206.
• [12]Parkes CM, Weiss R: Recovery from bereavement. New York: Basic books; 1983.
• [13]Hendriks KSWH, Hendriks MWB, Birnie E, Grosfeld FJM, Wilde AA, van den Bout J, Smets EM, van Tintelen JP, ten Kroode HF, van Langen IM: Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Hear Rhythm 2008, 5:719-724.
• [14]Hamang A, Eide GE, Nordin K, Rokne B, Bjorvatn C, Øyen N: Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population. BMC Med Genet 2010, 11:27.
• [15]Solberg EE, Bjornstad TH, Andersen TE, Ekeberg O: Cardiovascular preparticipation screening does not distress professional football players. Eur J Cardiovasc Prev Rehab 2011. published online first
• [16]Ingles J, Lind JM, Phongsavan P, Semsarian C: Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genet Med 2008, 10(2):117-20.
• [17]van Maarle MC, Stouthard MEA, Bonsel GJ: Quality of life in a family based genetic cascade screening programme for familial hypercholesterolaemia: a longitudinal study among participants. J Med Genet 2003, 40:e3.
• [18]Zigmond AS, Snaith PR: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67:361-370.
• [19]Ware JE, Kosinski M, Gandek B, Sundaram M, Bjorner JB, Turner-Bowker DM, et al.: User’s manual for the SF-12v2 Health Survey. 2nd edition. Lincoln, RI: QualityMetric Incorporated; 2010.
• [20]Snaith RP: The hospital anxiety and depression scale. Health Qual Life Outcomes 2003, 1:29. BioMed Central Full Text
• [21]Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002, 52:69-77.
• [22]Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-333.
• [23]Hamang A, Eide GE, Rokne B, Nordin K, Bjorvatn C, Øyen N: Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of Long QT syndrome or hypertrophic cardiomyopathy: A one year follow-up. J Genet Counsel 2012, 21:72-84.
• [24]Paris MM, Carter BL, Day SX, Armsworth MW: Grief and trauma in children after the death of a sibling. J Child Adolesc Trauma 2009, 2:71-80.
• [25]Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AAM, Smets EMA: Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: A cross sectional cohort study. Am J Med Genet 2009, 149A:602-612.
• [26]Lee A, Ackerman MJ: Sudden unexplained death: evaluation of those left behind. Lancet 2003, 362:1429-1430.
• [27]Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AAM, Smets EMA: Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients’ perspective. Am J Med Genet 2009, 149A:1444-1451.
• [28]Hamang A, Eide GE, Rokne B, Nordin K, Bjorvatn C, Oyen N: Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow up. J Genet Counsel 2012, 21:72-84.
• [29]Morgan JF, O’Donoghue AC, McKenna WJ, Schmidt MM: Psychiatric disorders in hypertrophic cardiomyopathy. Gen Hosp Psychiatry 2008, 30:49-54.
• [30]Ingles J, Yeates L, Hunt L, McGaughran J, Scuffham PA, Atherton J, Semsarian C: Health status of cardiac genetic disease patients and their at-risk relatives. Int J Cardiol 2011.
• [31]Cox S, O’Donoghue AC, Steptoe A, McKenna: Health-related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart 1997, 78:182-187.
• [32]Steptoe A, Mohabir A, Mahon NG, McKenna WJ: Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy. Heart 2000, 83:645-650.
• [33]Hendriks KS, Grosfeld F, van Tintelen J, van Langen I, Wilde A, van den Bout J, ten Kroode H: Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet 2005, 138A:107-112.
• [34]Melhelm NM, Porta G, Walker Payne M, Brent DA, Shamseddeen: Grief in children and adolescents bereaved by sudden parental death. Arch Gen Psychiatry 2011, 68:911-919.
• [35]Poole NA, Morgan JF: Validity and reliability of the Hospital Anxiety and Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a cardiomyopathy population. Gen Hosp Psychiatry 2006, 28:55-58.